Celecoxib: Cardiovascular Risk No Worse Than That of Nonselective NSAIDs

NEW ORLEANS — The cardiovascular safety profile of the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, a selective inhibitor of COX-2, is no worse than those of the nonselective NSAIDs naproxen and ibuprofen, according to a trial reported at the American Heart Association scientific sessions.

Source: Caring for the Ages - January 31, 2017 Category: Health Management Authors: Susan London Source Type: news